Definitive Healthcare

2 weeks ago | definitivehc.com | Nicole Witowski

New Orleans hosted this year’s MAPS Americas Conference, where more than 1,500 medical affairs leaders gathered for a deep dive into the forces reshaping the function. Over several days, the field’s brightest minds discussed everything from the rise of GenAI to the push for health equity. Definitive Healthcare was proud to join that conversation, leading a session on how data is reshaping KOL engagement in the real world. Couldn’t attend?

2 weeks ago | definitivehc.com | Nicole Witowski

After a sluggish 2024, many in the life sciences world hoped 2025 would usher in a revival for big-ticket biopharma mergers and acquisitions. But as the first quarter has closed, that hope remains largely unfulfilled. While a few notable deals have emerged, a confluence of political and economic uncertainties has kept the brakes on pharma M&A — at least for now.

1 month ago | definitivehc.com | Nicole Witowski

Cancer patients and their caregivers often turn to online communities to share their experiences, seek advice, and express frustrations. These digital footprints provide a wealth of insight into the patient journey — but how can life sciences companies effectively tap into this information? To explore this, we employed natural language processing (NLP) and large language models (LLMs) to analyze patient-generated content. The result?

2 months ago | definitivehc.com | Nicole Witowski

The design of healthcare environments is an often overlooked factor in patient recovery, but recent studies suggest it can affect health outcomes. From the presence of natural light to noise reduction, the very structure of a clinical environment has the potential to aid or impede a patient’s recovery, with far-reaching implications for both patient outcomes and the efficiency of care delivery.

Jan 30, 2025 | definitivehc.com | Nicole Witowski

The field of oncology is evolving, and one of the drivers of this change is the growing adoption of minimal residual disease (MRD) testing. While traditional imaging and blood tests often fall short of identifying MRD in its earliest stages, recent advancements in MRD-testing technologies are helping clinicians detect cancer cells earlier, providing crucial insights into cancer progression, recurrence, and treatment effectiveness.